Rx Firms Still Bear Promotional Compliance Burden If Social Media Platform Changes, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency’s advertising office Director Tom Abrams offers hints of FDA’s thinking ahead of the infamously delayed social media guidance.